NATIONAL BANK OF CANADA /FI/
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 926171
MONTREAL, A8
Position in REGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$78,448,813
-$21,999,021 QoQ
Shares Held
125,812
-3.2% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#99
of 1,322 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 0%
Shared 88%
None 12%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NATIONAL BANK OF CANADA /FI/ holds $632,188,402 across 150 Biotechnology names. REGN ranks #5 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
1,096,025 | $205,263,562 | |
| 2 | MRNA |
Moderna, Inc.
|
1,424,802 | $99,778,883 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
2,773,874 | $98,167,400 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
172,898 | $85,883,622 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
125,812 | $78,448,813 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
52,467 | $15,794,140 | |
| 7 | GPCR |
Structure Therapeutics Inc.
|
215,800 | $11,581,986 | |
| 8 | ABCL |
AbCellera Biologics Inc.
|
1,233,014 | $9,679,159 |
All Filings in REGN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,448,813 | 125,812 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $100,447,834 | 130,006 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $92,479,288 | 119,812 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $92,428,752 | 164,385 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $62,144,390 | 97,984 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $73,833,714 | 103,651 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $74,805,185 | 71,159 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $44,977,776 | 42,794 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $43,447,759 | 45,141 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $102,081,011 | 116,227 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $36,530,370 | 44,389 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $27,357,691 | 38,074 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $12,488,561 | 15,199 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $10,408,214 | 14,426 | Shares | Defined | 2023-01-24 | |
| 2022-09-30 | $6,468,488 | 9,390 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $6,176,716 | 10,449 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $4,889,638 | 7,001 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $5,253,614 | 8,319 | Shares | Defined | 2022-01-24 | |
| No filing history on record for this holder in this stock. | ||||||